Release date: 2024-08-06 13:47:49 Article From: Lucius Laos Recommended: 157
Exkivity is available in multiple versions, including innovator versions and multiple generic versions. These versions may vary based on factors such as different manufacturers, drug specifications, drug names, and market regions. Patients should consider factors such as price, quality, efficacy, and individual circumstances when choosing and making decisions under the guidance of doctors.
Here are some of the main release information:
Japan Takeda Pharmaceutical Edition: This is the original drug version of Exkivity, and the trade name in the Chinese market is Anweili. This version was approved for marketing in China on January 11, 2023, and is primarily used for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 20 insertion mutations (ex20ins).
The generic version of Exkivity manufactured by Lucius Pharmaceuticals Laos is a version on the market, and its price and quality may vary depending on the channel and production lot.
Lucius Pharmaceuticals India also produces a generic version of Exkivity, which has a certain market share in and around India.
Moboxen, manufactured by Everest Pharmaceuticals in Bangladesh, is a generic version of another Exkivity, which has some sales in Bangladesh and other countries.
In addition to the above versions, there may be other unmentioned versions of Exkivity on the market. These versions may be developed based on different market needs, regulatory requirements, or manufacturers.
Laos Lucius Pharmaceutical Co., Ltd. is a large-scale generic drug production company, which produces generic drugs with the following characteristics:
Lucius Pharmaceutical's generic drugs strictly follow international pharmaceutical manufacturing standards to ensure that they are identical or similar to the original drugs in terms of active ingredients, dosage forms, routes of administration, and therapeutic effects. These generic drugs have been verified in terms of efficacy and safety and can be used as a substitute for the original drug.
Compared with the original drug, Lucius Pharmaceutical's generic drug has a significant price advantage. This has made treatment more affordable for more patients and improved access to medicines.
Lucius Pharmaceuticals covers a variety of pharmaceutical fields, including antineoplastic drugs, cardiovascular drugs, hematology drugs, diabetes drugs, dermatology drugs, and more than 200 drug categories. Among them, the generic drug of Exkivity produced by the company is an effective treatment option for patients with specific EGFR mutation types of non-small cell lung cancer (NSCLC).
【Warm tips】Please follow the doctor's advice for regular follow-up visits so that the doctor can keep abreast of the changes in your condition and the effect of treatment, and adjust the treatment plan.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: